Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Atopic DermatitisPsoriasis
Interventions
DRUG

Vitamin D3

Administration of oral vitamin D3 at 4000IU

DRUG

Placebo

Administration of oral Vitamin D3 placebo

Trial Locations (3)

80206

National Jewish Health, Denver

92037

University of California, San Diego, San Diego

97239

Oregon Health & Science University, Portland

Sponsors
All Listed Sponsors
collaborator

Consortium of Food Allergy Research

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH